• High-Throughput BBB Model Enhances CNS Drug Screening Accura

  2026-04-30

  This study introduces a robust surrogate blood-brain barrier (BBB) model using LLC-PK1-MOCK/MDR1 cells combined with lysosomal trapping correction, providing high predictive accuracy for CNS drug permeability. Its findings lay the groundwork for more efficient early-stage screening of brain-penetrant compounds and address longstanding challenges in modeling BBB transport mechanisms.

• Carbon-Ion Radiotherapy Induces Ferroptosis in Gastric Cance

  2026-04-30

  Wang and Cai (2025) reveal that carbon-ion radiotherapy (CIRT) suppresses gastric cancer progression by inducing ferroptosis and promoting M1 macrophage polarization through downregulation of DHODH. This mechanistic insight highlights a potential strategy to enhance radiotherapy efficacy in treatment-resistant gastric tumors.

• Haloprogin: Broad-Spectrum Antifungal and Antibacterial Insi

  2026-04-29

  The landmark 1970 study systematically established Haloprogin (1,2,4-trichloro-5-((3-iodoprop-2-yn-1-yl)oxy)benzene) as an effective topical antifungal agent with a uniquely broad spectrum, including potent activity against dermatophytes, Candida species, and selected Gram-positive bacteria. These findings inform contemporary protocols for infection model research and highlight Haloprogin’s distinct profile versus tolnaftate.

• Redefining α2-AR Agonists: Translational Leverage in Osteosa

  2026-04-29

  This article reframes the application of 5-bromo-N-(4,5-dihydro-1H-imidazol-2-yl)quinoxalin-6-amine, a selective α2-adrenergic receptor agonist, for translational researchers targeting post-surgery osteosarcoma recurrence. Integrating mechanistic insight, rigorous experimental validation, and strategic guidance, we map out new opportunities for immune rejection modulation and advanced drug delivery. Drawing from the latest published study and related expert resources, this analysis not only benchmarks APExBIO’s offering in the research reagent landscape but also sets a forward-looking agenda for next-generation receptor signaling research.

• hiPSC-Derived Intestinal Organoids: Advances for PK Studies

  2026-04-28

  This study presents a streamlined protocol to generate human intestinal organoids from pluripotent stem cells, enabling robust in vitro pharmacokinetic analysis. By improving physiological relevance over traditional models, this work offers a scalable platform for drug absorption and metabolism studies.

• G418 Sulfate (Geneticin): Mechanism, Evidence, and Applicati

  2026-04-28

  G418 Sulfate (Geneticin) is a high-purity aminoglycoside antibiotic essential for genetic engineering selection and antiviral research. It acts via 80S ribosome inhibition, reliably selects neomycin-resistant cells, and demonstrates antiviral activity against Dengue virus serotype 2. Supported by peer-reviewed evidence and robust product specifications, it is a cornerstone for modern cell culture workflows.

• ONX-0914 (PR-957): Protocol Optimization in Autoimmune Model

  2026-04-27

  ONX-0914 (PR-957) empowers researchers to dissect immunoproteasome function with unmatched selectivity, accelerating breakthroughs in autoimmune disease and cytokine modulation. This guide distills experimental workflows, troubleshooting strategies, and novel insights from the latest airway epithelium research for real-world bench applications.

• Genistein in Cancer Chemoprevention: Protocols and Innovatio

  2026-04-27

  Genistein, a 5,7-dihydroxy-3-(4-hydroxyphenyl)chromen-4-one, is redefining cancer biology research through selective tyrosine kinase inhibition and cytoskeleton-driven mechanotransduction. This guide delivers actionable protocols, troubleshooting strategies, and cutting-edge insights that bridge autophagy research with applied cancer chemoprevention.

• MRT68921 ULK1 Kinase Inhibitor: Precision Autophagy Blockade

  2026-04-26

  MRT68921, a dual ULK1/2 kinase inhibitor from APExBIO, offers nanomolar precision for dissecting autophagy pathways, enabling robust ATG13 phosphorylation blockade and LC3 flux quantification. This article translates recent lipid autophagy advances into practical protocols and troubleshooting tips for researchers seeking next-level control over cellular homeostasis studies.

• Cell Line and Reporter Gene Impact on mRNA-LNP Transfection

  2026-04-25

  Zhen et al. (2025) systematically evaluated how cell line and reporter gene selection affect in vitro mRNA-LNP transfection efficiency assays. Their findings highlight the critical importance of model and assay design for generating reproducible, interpretable data in mRNA delivery research.

• Norovirus Hijacks NINJ1 for Selective NS1 Secretion: Mechani

  2026-04-24

  This study uncovers how murine norovirus (MNoV) exploits host NINJ1 protein to selectively secrete its viral NS1 protein via an unconventional pathway. The findings provide a mechanistic framework for understanding regulated plasma membrane rupture and selective protein secretion during viral infection, with implications for cell death and immune evasion research.

• Sulfo-NHS-SS-Biotin: Advanced Proteostasis Mapping in Membra

  2026-04-24

  Explore how Sulfo-NHS-SS-Biotin enables precise, reversible biotinylation for advanced studies of membrane protein proteostasis. This article uniquely connects the reagent’s cleavage chemistry with emerging insights into protein folding, trafficking, and quality control, highlighting its utility in next-generation assay design.

• Cy3 NHS Ester (Non-Sulfonated): Technical Use and Workflow G

  2026-04-23

  Cy3 NHS ester (non-sulfonated) enables robust fluorescent labeling of proteins, peptides, and oligonucleotides via amino group conjugation, delivering high sensitivity for biomedical imaging. It is ideal when high solubility in DMSO or ethanol is required but should be avoided for delicate proteins or applications incompatible with organic co-solvents. The product is not suited for protocols demanding water-only solubility or long-term solution storage.

• Silybin A in Liver Disease Research: Applied Protocols & CRI

  2026-04-23

  Silybin A, a principal component of silymarin, is redefining hepatoprotective and metabolic studies through its antioxidant and signaling-modulating actions. This article delivers a bench-to-publication guide, linking Silybin A’s unique properties and solubility constraints to modern workflows, including synergy with CRISPRi-based metabolic interventions.

• HDAC Inhibition Reverses EBV-Induced Dedifferentiation in NP

  2026-04-22

  This study elucidates how EBV latent protein LMP1 drives dedifferentiation and stem-like plasticity in nasopharyngeal carcinoma (NPC) by repressing CEBPA via HDAC-mediated chromatin remodeling. The authors demonstrate that HDAC inhibition restores differentiation, offering a mechanistic basis for epigenetic differentiation therapy in solid tumors.

15847 records 1/1057 page Next 12345 下5页 Last page